2,4-Dimethyl-5-vinylthiazole
Common Name: |
2,4-Dimethyl-5-vinylthiazole |
IUPAC Name: |
5-ethenyl-2,4-dimethyl-1,3-thiazole |
Molecular Formula: |
C7H12O2 |
SMILES: |
CC1=C(SC(=N1)C)C=C |
Inchi: |
1S/C7H9NS/c1-4-7-5(2)8-6(3)9-7/h4H,1H2,2-3H3 |
Inchi Key: |
MLBCDQHOBLVBQD-UHFFFAOYSA-N |
Cas No: |
65505-18-2 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
128.17 |
Mass (g/mol) |
139.046 |
Molar Refractivity |
37.06 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
37.30 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
183.00 to 184.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.414 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.57 |
LogP |
2.403 |
iLOGP |
1.79 |
XLOGP3 |
1.75 |
WLOGP |
1.67 |
MLOGP |
1.52 |
ESOL Log S |
-1.61 |
ESOL Solubility (mg/ml) |
3.18 |
ESOL Solubility (mol/l) |
0.025 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.15 |
Ali Solubility (mg/ml) |
0.91 |
Ali Solubility (mol/l) |
0.01 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-0.51 |
Silicos-IT Solubility (mg/ml) |
39.2 |
Silicos-IT Solubility (mol/l) |
0.31 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.84 |
Bioavailability Score |
0.85 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.747 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.744 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |